Guilene Davilmar, ARNP

Guilene Davilmar practices at Health First Medical Group in Rockledge, Florida.

Guilene Davilmar's NPI, 1669994083, was assigned on July 7, 2017. Guilene Davilmar holds Florida license ARNP3265502.

Guilene Davilmar's primary practice is Health First Medical Group, at 3300 S Fiske Blvd, Rockledge, FL 32955 in Brevard County. The practice phone is (321) 434-5055.

Guilene Davilmar's primary practice is Health First Medical Group in Rockledge, Florida. Guilene Davilmar is also affiliated with Holmes Regional Medical Center. The medical group on file is Health First Medical Group (Formerly Mima). Dmand AI also links Guilene Davilmar to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Guilene Davilmar practices, 5 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Guilene Davilmar's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Guilene Davilmar is licensed in Florida.

Dmand AI lists acute gastroduodenitis, alcohol use disorders, chronic indigestion, gastroenteritis, hemorrhoids, tobacco use and yeast infection among the conditions Guilene Davilmar treats.

CMS data shows 576 Medicare services from Guilene Davilmar across 6 procedure codes in 2024, for 373 Medicare patients. Medicare paid $49,189 for them. Every service was in an office.

CMS counts 373 Medicare patients who saw Guilene Davilmar in 2024. The largest group is 65 to 74, with 180 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Guilene Davilmar's median patient age at 65, with 69% women.

In 2024, Guilene Davilmar wrote 2,156 Medicare Part D claims for 595 patients. 93% of them were for generic drugs. CMS names the drug for 2,055 of them, across 18 drugs with 11 or more claims each, at $167,264 in total drug cost.

Guilene Davilmar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Guilene Davilmar as offering telehealth.

CMS Open Payments shows 10 general payments to Guilene Davilmar from 5 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $601.